Skip to main content
. 2012 Mar 14;2012:913848. doi: 10.1155/2012/913848

(a) Inclusion criteria

Criteria Number of patients
1 Number of beneficiaries under 65 at eligibility start 4,729,443
2 >1 breast, ovarian, head and neck, or nonsmall cell lung cancer claim from 1999–2005 56,261
3 >1 chemotherapy treatment within 3 months following a breast, ovarian, head and neck, or nonsmall cell lung cancer diagnosis 14,142
4 >3 months of continuous eligibility prior to the first chemotherapy treatment for the qualifying tumor during which no other chemotherapy treatment was received 11,009
5 >1 diagnosis for peripheral neuropathy following first chemotherapy treatment 1,245
6 Peripheral neuropathy within 9 months of first chemotherapy treatment 525
Main CAPN sample: no diabetes history 454
Diabetic CAPN sample 71
Employee CAPN subsample 78